Member Info for redboy33

Thanks again and if I hear anything I will share.

Time for a glass of wine now....I guess it will have to be Red tonight!

Thank you for the responses............interesting........wonder if something is happening. Personally would prefer that ODX invested in a Communications Director (and not use a PR company) who could perhaps also motivate the (apparently quite shy) Sales guys to promote the exciting new products ODX have done a great job developing.
Thanks again and ATB for weekend and a better week (next).
Red

Any one had any email correspondence from Walbrook this week? Sent an e mail last weekend and no response. Usually found they reply within a couple of days.
Thanks
Red

Must admit I stopped reading your post as soon as you said "let's be honest....":-)

Good Evening,
I believe it was originally reported as Unknown as the spread was 71 - 73 and then the UT was reported at 72 and it's status was changed to a sell. Just my opinion but I think it may have been a Buy as the Ask moved up at 1617, but could be wrong.
ATB
Red

Good Morning,

Please find below, for information, an e mail response I received from Paul (Walbrook) this morning, whereby I was asking if everything with regards Mologic TT completion (for April – i.e. by end of this week) was on track.

“Omega said that they are expecting marketing launch for commercial roll-out to take place in April – nothing has changed and you can expect an announcement when that happens.

In terms of questions from investors – Walbrook liaises with Colin on all investor relations matters. He and I speak or communicate almost daily. Walbrook answers all questions that are sent to us. We also respond to enquiries that are directed to Colin and which he passes to us. Colin has received a high volume of collated questions recently and these are being answered by us.

As you know we’re happy to answer questions that investors have about Omega – we’re not always able to provide the answers investors want, but we will still respond as best we can.”

ATB for a great week to everyone,

Red

Good Morning,
Yes of course.
ATB
Red

Colin gave the milestones for all 3 examples during the presentations the most famous being the TT as a Xmas present or early NY.

The examples (3) were stated in the e mail of 20th April.

Good Afternoon,

Just sharing an email exchange with Walbrook and fully appreciate that some may not agree with position but I have a significant investment and while I believe there is great potential here I am very disappointed about the minimal/inconsistent communications

Question 20/04/21 16:47
“Obviously it is disappointing over the last few weeks to experience a continuing decline in SP and I am sure many investors are concerned there has been little news from Omega. I appreciate that their position might be that there is no new news to currently give and as soon as they will have, they will immediately release an RNS. However, I respectfully suggest that investors will feel that news about “Food Detective” was released significantly after ODX indicated (albeit this was due to CV19 in China), MHRA ABC Home use approval still o/s versus an indicative approval in August (again appreciate this was/and is not in ODX’s control) and TT of Mologic Antigen December/January. So whereas 2 of the 3 mentioned are outside ODX’s control surely it is a better policy to be proactive on Comms and each month provide an update on all o/s projects/initiatives even if it is, “no change” to the previous period, as it would at least serve to give reassurance to shareholders that all is well just taking a little longer because of xyz and thus avoid investors having to pester yourself for information?

Sorry I know you will probably be receiving many comms from investors but just think more regular communications from ODX will make life easier for all.”

Response 21/04/21
“It’s just simply not possible to provide the regular update on progress that you suggest, unless they have something to say. RNS announcements are not designed to provide a running monthly commentary on what has or hasn’t progressed. RNS announcements are issued when something of materiality has happened and if there is no new news to update on the Company isn’t going to put out an RNS saying that there is nothing new to update on. Obviously if there is something significant to say they will say it and I can assure you that we are encouraging the Company to provide updates when they can – we don’t invent the news nor can force it to happen. We can only communicate when the Company has something to say. Suffice to say I’ll happily pass on your feedback to the Company.”

My Reply 21/04/21
“Thank you Paul. However, the main point of my e mail (and I suspect the concern of many) is why there has been consistent failures to achieve milestones communicated by the company or at very least to provide updates as to why these milestones have not been met? Everyone can accept (yes we might moan about it) projects can be delayed (in my experience they often are) but to be silent (and see a 30% drop in SP in recent weeks), in my experience is not a good policy and I respectfully disagree that providing updates when milestones have failed is most definitely worthy of news and an RNS.”

ATB
Re

NP. I topped up again today and thought I'd done great at 77p! Well tomorrow is another day!
ATB
Red

Hi Benny,
I don't actually know him but I follow ODX on Twitter and at about 1750 he posted his e mail question and Paul's (Walbrook) response and virtually identical to mine that I received about 1800. I'm sorry I cannot reproduce here but similar to what I posted earlier on LSE. I haven't noticed Neil posting on Twitter before and dont think he is a regular but might be wrong. I replied to him that I had received similar reply from Paul.
ATB
Red

Good Evening Tricky,

I asked a similar question last week to Walbrook and received the following response:

"Regarding the RADX initiative with Mologic – the self test mentioned is not the test Omega is working on."

Apologies for not sharing this earlier.

ATB

Red

Good Evening,

On Wednesday I asked the following question of Walbrook....

Question: "I am becoming a little concerned at the constant drop in SP (along with some large sells at end today). Could you just confirm that all is on track for completion of the TT and commercial launch of the VISITECT LFT in April for sale to professional users? "

I received a response this evening which seems consistent to one posted on Twitter this evening by Neil Henshaw

Answer: "In terms of Tech Transfer Omega announced in March that the Company has received CE marking for the test - this means that the process of technology transfer has reached the stage that the Company is satisfied that they are able to reproduce the test to scale to the specifications laid out in the technical files submitted for CE marking, which is positive news. The process is ongoing but the next key milestone is when the product is launched by Omega for sale under their own brand (which surpasses completion of the tech transfer in terms of meaningful news). Nothing has changed in their expectations regarding when this will happen. As you know they have not given a specific date for when the launch will happen so all I can say is that an announcement will be made in due course."

Please note the delay in response from Walbrook is my fault as Paul was not available and I didn't copy in the PR address.

ATB
Red

Good Evening Fb,
Yes it would seem that way. I hoped there may have been some tweeting to acknowledge/comment (just my opinion) but suspect there may be some news next week
Have a good weekend.
Red

I posted on Wed. 17:26 regards the lack of comms. (in my opinion) and have reproduced the e mail below and the update I have received today (from Walbrook) to the first question.

“Q1: Today I understand ABDX have received news from the FDA that their ABC Rapid Test has gained trademark approval.
https://uspto.report/TM/88896035/PB320210406025659/

Q2: In addition Mologic have confirmed their test has been selected for the @NIH RADx program. Possibly this is an indication that the UK government will name this as their preferred test.

Will ODX be tweeting any comments regards either of these news pieces?”

Walbrook response today to Q1 ……… “I have heard back from the Company regarding your first question.

Please be advised that the TM and logo were accepted but not yet registered.

I will endeavour to answer the second question early next week.”

To be fair (regards Q1) I had probably misunderstood and does not (now) seem that significant news really and maybe Q2 might need input from CK.

Have a great weekend and hopefully we all have a fantastic next week.

ATB

Red

I contacted Walbrook yesterday to enquire whether ODX would be commenting (via twitter) as to the news regards FDA confirming ABC Rapid Test trademark and Mologic confirming their test had been selected for the @NIH RADx program (I also added a comment that presumably in the latter case this might indicate the government’s preferred test).

Paul is on holiday but I was advised that my question would be forwarded. I had not heard anything by 1541 today so chased up and advised nothing yet and will respond when they have an answer.

Having tweeted in regards the newspaper headlines I (perhaps foolishly) thought the news yesterday would have warranted a comment/tweet but perhaps my impatience is getting the better of me and there will be something official tomorrow. If I receive anything directly I will share.

ATB
Red

I have just noticed an MM "ARDA" on L2. I don't recall these before. Are they a new MM?
Thanks
Red

Good Evening,

Suggestions today of shortage in vaccine availability
https://www.msn.com/en-gb/news/coronavirus/uk-to-face-significant-reduction-in-covid-vaccine-supplies-from-29-march/ar-BB1eGzWP?ocid=msedgntp

I had my first jab last Tuesday (AZ) and whereas I have my second appointment confirmed in May I have suggested to my neighbours (I am an NHS volunteer) that they should try and secure their second vaccine appointments asap as I expect to see my appointment postponed/cancelled due to availability of vaccine and/or new/updated govt strategy to introduce antibody testing in order to ensure the (potential) limited vaccine stock is prioritised to those that require it, just my opinion.
ATB
Red

Good Evening,
I have not been monitoring L2 today but there are 2 MM's (CFEP and SCAP) on the ASK at 0.37p. I assume form Yanis' post there were possibly more earlier and once these 2 have sold what they hold the ASK will move up.
Apologies if I have misunderstood the question.
Red